Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3277613
Max Phase: Preclinical
Molecular Formula: C16H39ClN4S2
Molecular Weight: 350.64
Molecule Type: Small molecule
Associated Items:
ID: ALA3277613
Max Phase: Preclinical
Molecular Formula: C16H39ClN4S2
Molecular Weight: 350.64
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.NCCCCCCNCCSSCCNCCCCCCN
Standard InChI: InChI=1S/C16H38N4S2.ClH/c17-9-5-1-3-7-11-19-13-15-21-22-16-14-20-12-8-4-2-6-10-18;/h19-20H,1-18H2;1H
Standard InChI Key: GPYNOGCPMUJTBM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 350.64 | Molecular Weight (Monoisotopic): 350.2538 | AlogP: 2.59 | #Rotatable Bonds: 19 |
Polar Surface Area: 76.10 | Molecular Species: BASE | HBA: 6 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 10.67 | CX LogP: 1.45 | CX LogD: -8.56 |
Aromatic Rings: 0 | Heavy Atoms: 22 | QED Weighted: 0.21 | Np Likeness Score: 0.14 |
1. Melchiorre C, Yong MS, Benfey BG, Belleau B.. (1978) Molecular properties of the adrenergic alpha receptor. 2. Optimum covalent inhibition by two different prototypes of polyamine disulfides., 21 (11): [PMID:31477] [10.1021/jm00209a007] |
Source(1):